Drug intelligence / Profile preview

French lyophilized plasma

Development stage
Phase 3
Lead developer
Centre de Transfusion Sanguine des Armées
Administration
Intravenous
01

Overview

**French lyophilized plasma** is a pathogen-reduced, leukocyte-depleted, pooled human plasma product manufactured by the French Military Blood Institute. It is supplied as freeze-dried plasma for rapid reconstitution and intravenous transfusion in severe bleeding emergencies. The product replaces depleted or consumed plasma coagulation proteins, including fibrinogen and other clotting factors, to support hemostasis and correct trauma-induced coagulopathy during hemorrhagic shock. Its room-temperature storage, universal compatibility, and rapid reconstitution make it particularly suitable for military, austere, and prehospital trauma care. French lyophilized plasma has been studied in Phase 3 trauma trials including TRAUCC and PREHO-PLYO. ([jthjournal.org](https://www.jthjournal.org/article/S1538-7836%2822%2902641-1/fulltext))

Brand names
PLYOPLASMA
Other names
FLyPPLYOplasma lyophiliséFrench FDP
02

Targets

F (Coagulation factors)

Beyond the preview

Go deeper on French lyophilized plasma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on French lyophilized plasma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call